Community Mortality Due to Respiratory Syncytial Virus in Argentina: Population-based Surveillance Study
Overview
Authors
Affiliations
Background: Many deaths in infants from low-middle income countries (LMICs) occur at home or upon arrival to health facilities. Although acute lower respiratory tract illness plays an important role in community mortality, the accuracy of mortality rates due to respiratory syncytial virus (RSV) remains unknown.
Methods: An active surveillance study among children aged under 5 years old (U5) was performed in Buenos Aires, Argentina, between January and December 2019, to define the burden and role of RSV in childhood community mortality.
Results: A total of 63 families of children U5 participated in the study. Based on a combined approach of tissue sampling, verbal autopsies, and expert's analysis, RSV infection was found in the causal chain of 11 from 12 cases with positive molecular biology results in respiratory samples. The estimated mortality rate due to RSV among infants was 0.27 deaths/1000 live births. The mean age of RSV-related household deaths was 2.8 months of age (standard deviation [SD] 1.7), and 8/12 were male infants (66.7%). Dying at home from RSV was associated with Streptococcus pneumoniae and/or Moraxella catarrhalis lung coinfection (75%), living in slums and settlement (odds ratio [OR], 17.09; 95% confidence interval [CI], 1.3-219.2), and other underlying comorbidities (OR, 14.87; 95% CI, 1.3-164.6).
Conclusions: Infant community mortality rates due to RSV are higher than those reported in industrialized countries and similar to those reported in hospital-based studies in the same catchment population.
Dvorkin J, Pecenka C, Sosa E, Sancilio A, Duenas K, Rodriguez A BMJ Public Health. 2025; 2(1):e000975.
PMID: 40018190 PMC: 11812910. DOI: 10.1136/bmjph-2024-000975.
Wheelock A, Chasaya M, Namuziya N, Jumbe Marsden E, Kapasa M, Mumba C J Pediatric Infect Dis Soc. 2025; 14(1.
PMID: 39786450 PMC: 11748213. DOI: 10.1093/jpids/piae129.
Rey-Ares L, Averin A, Zuccarino N, Vega C, Kutrieb E, Quinn E Infect Dis Ther. 2024; 13(11):2363-2376.
PMID: 39365506 PMC: 11499499. DOI: 10.1007/s40121-024-01055-5.
Guinazu G, Dvorkin J, Mahmud S, Baral R, Pecenka C, Libster R Vaccine. 2024; 42(23):126234.
PMID: 39154512 PMC: 11413482. DOI: 10.1016/j.vaccine.2024.126234.
Dvorkin J, Sosa E, Vodicka E, Baral R, Sancilio A, Duenas K BMC Public Health. 2024; 24(1):427.
PMID: 38336643 PMC: 10858556. DOI: 10.1186/s12889-024-17878-3.